This review integrates current understanding of SHP-1 regulatory mechanisms, disease-specific evidence, and emerging translational opportunities, highlighting <i>PTPN6</i>/SHP-1 as a candidate target for precision immunomodulation in autoimmune disease. The gene discussed is PTPN6; the disease is autoimmune disease.